6 research outputs found
Recommended from our members
Optimisation of recombinant production of active human cardiac SERCA2a ATPase
Methods for recombinant production of eukaryotic membrane proteins, yielding sufficient quantity and quality of protein for structural biology, remain a challenge. We describe here, expression and purification optimisation of the human SERCA2a cardiac isoform of Ca2+ translocating ATPase, using Saccharomyces cerevisiae as the heterologous expression system of choice. Two different expression vectors were utilised, allowing expression of C-terminal fusion proteins with a biotinylation domain or a GFP- His8 tag. Solubilised membrane fractions containing the protein of interest were purified onto Streptavidin-Sepharose, Ni-NTA or Talon resin, depending on the fusion tag present. Biotinylated protein was detected using specific
antibody directed against SERCA2 and, advantageously, GFP-His8 fusion protein was easily traced during the purification steps using in-gel fluorescence. Importantly, talon resin affinity purification proved more specific than Ni-NTA resin for the GFP-His8 tagged protein, providing
better separation of oligomers present, during size exclusion chromatography. The optimised method for expression and purification of human cardiac SERCA2a reported herein, yields purified protein (> 90%) that displays a calcium-dependent thapsigargin-sensitive activity and is suitable for further biophysical, structural and physiological studies. This work provides support for the use of Saccharomyces cerevisiae as a suitable expression system for recombinant production of multi-domain eukaryotic membrane proteins
Normalised specific ATPase activity rate versus Ca<sup>2+</sup> dependence for DDM solubilised <i>h</i>SERCA2a after HPLC-SEC purification.
<p>100% specific ATPase activity corresponds to 3 µmol hydrolysed ATP/min/mg of <i>h</i>SERCA2a. The results are the means of seven measurements, using protein obtained from three independent membrane preparations; error bars represent ±S.D.</p
Purification of <i>h</i>SERCA2a-Biotin fusion protein using Streptavidin-Sepharose resin.
<p><b>A</b>. Coomassie stained 12% Tris-Glycine SDS PAGE gel from purification, M- protein ladder, HS-high salt wash, LS-low salt wash, FT- flow-through after binding to Streptavidin resin, R-resin with bound hSERCA2a, FTC- flow-through concentrated, E – elution from Streptavidin resin, C- concentrated sample prior to gel filtration, GF- elution after gel filtration, rS1a- rabbit SERCA1a, 1µg. <b>B</b>. HPLC-SEC profile for hSERCA2a after Streptavidin affinity purification using 12L culture. DDM detergent was exchanged on gel filtration column with C<sub>12</sub>E<sub>8</sub> detergent. <b>C</b>. Coomassie stained 4-12% Bis-Tris SDS PAGE gel. SEC fractions obtained for <i>h</i>SERCA2a purified with Streptavidin resin.</p
Talon resin affinity purification of <i>h</i>SERCA2a-GFP-His<sub>8</sub>.
<p>Protein was obtained using minimal media. <b>A</b>. Coomassie stained SDS-PAGE gel; <b>B</b>. In gel fluorescence 12% Tris-Glycine SDS-PAGE gel, MF- fluorescent protein ladder; MB- membranes fraction; S- solubilised fraction; FT- flow-through after binding to Talon resin; W- wash fraction; E- elution; D- sample after cleavage with TEV protease and dialysis; R- sample after Ni-NTA reverse binding; C- sample concentrated, before gel filtration; rS1a- rabbit SERCA1a at; C- fraction containing <i>human</i> SERCA2a concentrated before gel filtration; W2- eluted material from Ni-NTA His trap after reverse Ni-NTA purification; M- protein ladder. <b>C</b>. HPLC-SEC profile for <i>h</i>SERCA2a purified using Talon resin. Protein was concentrated with 100 kDa cut-off filter concentrator and DDM detergent was exchanged on gel filtration column with C<sub>12</sub>E<sub>8</sub> detergent. <b>D</b>. Coomassie stained 4-12% Tris-Glycine SDS PAGE gel for SEC fractions obtained for purification of <i>h</i>SERCA2a using Talon super-flow resin.</p
Typical activity assay profile for purified recombinant <i>human</i> Ca<sup>2+</sup> ATPase isoform 2a (<i>h</i>SERCA2a).
<p>The protein was purified using -GFP-His<sub>8</sub> tag and Talon resin affinity purification. Reaction buffer used was as in Materials and Methods; the reaction was triggered by adding 5 µg of purified protein. Addition of thapsigargin inhibits activity of purified protein. Calcium-dependent activity corresponds to the difference of slope before and after thapsigargin addition. Here, final calcium-dependent ATPase activity is about 3 µmol hydrolysed ATP/min/mg of <i>h</i>SERCA2a.</p
Small scale expression test for <i>h</i>SERCA2a-GFP-His<sub>8</sub> using different clones.
<p><b>A</b>. SDS-PAGE 4-12% Tris-Glycine in gel fluorescence analysis. M-fluorescent ladder, 1-6 different <i>h</i>SERCA2a-GFP-His<sub>8</sub> clones; <b>B</b>. Western Blotting using specific <i>h</i>SERCA2 antibodies, MM – prestained protein ladder.</p